• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

轻度认知障碍中的主观记忆抱怨与记忆功能意识:一项系统综述

Subjective memory complaints and awareness of memory functioning in mild cognitive impairment: a systematic review.

作者信息

Roberts J L, Clare L, Woods R T

机构信息

Bangor University, Bangor, UK.

出版信息

Dement Geriatr Cogn Disord. 2009;28(2):95-109. doi: 10.1159/000234911. Epub 2009 Aug 13.

DOI:10.1159/000234911
PMID:19684399
Abstract

OBJECTIVES

Subjective memory complaint (SMC) is central to the diagnosis of mild cognitive impairment (MCI). People with MCI are at a higher risk of progressing to dementia, and research on SMC is contradictory in terms of the accuracy of SMC and its predictive role for future dementia. One possible reason for these contradictory findings is that the level of awareness of memory function may vary among people with MCI. This review examines whether the level of awareness of memory functioning varies amongst people classified as having MCI and whether there is support for the suggestion that the level of awareness in MCI predicts future progression to dementia.

METHOD

Sixteen studies were identified which evaluate the awareness level in people classified as having MCI in either a clinical or research setting. In addition to the outcome of each study, the conceptualization of awareness, 'object' of awareness and methodology were also considered.

RESULTS

There is evidence to show that the level of awareness in MCI does vary, and this may have implications for future progression to dementia.

CONCLUSIONS

Given the increased risk of progression to dementia for those identified as having MCI, the role of awareness should be explored further with due consideration given to the conceptualization of awareness and the methodology employed. The finding of variability in awareness has implications for the use of SMC in the diagnostic criteria for MCI.

摘要

目的

主观记忆主诉(SMC)是轻度认知障碍(MCI)诊断的核心。MCI患者发展为痴呆症的风险更高,而关于SMC的研究在SMC的准确性及其对未来痴呆症的预测作用方面存在矛盾。这些矛盾发现的一个可能原因是,MCI患者对记忆功能的认知水平可能存在差异。本综述探讨了被归类为MCI的人群中记忆功能的认知水平是否存在差异,以及是否支持MCI中的认知水平可预测未来发展为痴呆症这一观点。

方法

确定了16项研究,这些研究在临床或研究环境中评估了被归类为MCI的人群的认知水平。除了每项研究的结果外,还考虑了认知的概念化、认知的“对象”和方法。

结果

有证据表明,MCI中的认知水平确实存在差异,这可能对未来发展为痴呆症有影响。

结论

鉴于被确定为MCI的人群发展为痴呆症的风险增加,应进一步探讨认知的作用,同时适当考虑认知的概念化和所采用的方法。认知存在差异这一发现对SMC在MCI诊断标准中的应用具有影响。

相似文献

1
Subjective memory complaints and awareness of memory functioning in mild cognitive impairment: a systematic review.轻度认知障碍中的主观记忆抱怨与记忆功能意识:一项系统综述
Dement Geriatr Cogn Disord. 2009;28(2):95-109. doi: 10.1159/000234911. Epub 2009 Aug 13.
2
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.
3
Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment.尼麦角林治疗痴呆及其他与年龄相关的认知障碍形式的疗效。
Cochrane Database Syst Rev. 2001;2001(4):CD003159. doi: 10.1002/14651858.CD003159.
4
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
5
18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).使用氟代硼吡咯进行18F正电子发射断层显像以早期诊断轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012216. doi: 10.1002/14651858.CD012216.pub2.
6
Psychological treatments for depression and anxiety in dementia and mild cognitive impairment.痴呆和轻度认知障碍患者的抑郁和焦虑的心理治疗。
Cochrane Database Syst Rev. 2022 Apr 25;4(4):CD009125. doi: 10.1002/14651858.CD009125.pub3.
7
Vitamin E for Alzheimer's dementia and mild cognitive impairment.维生素E用于治疗阿尔茨海默病性痴呆和轻度认知障碍。
Cochrane Database Syst Rev. 2017 Apr 18;4(4):CD002854. doi: 10.1002/14651858.CD002854.pub5.
8
18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).使用氟代甲磺酸去甲肾上腺素的18F正电子发射断层显像用于轻度认知障碍(MCI)患者中阿尔茨海默病性痴呆及其他痴呆的早期诊断。
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012884. doi: 10.1002/14651858.CD012884.
9
Vitamin E for Alzheimer's dementia and mild cognitive impairment.维生素E用于治疗阿尔茨海默病性痴呆和轻度认知障碍。
Cochrane Database Syst Rev. 2017 Jan 27;1(1):CD002854. doi: 10.1002/14651858.CD002854.pub4.
10
Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly.胞二磷胆碱用于治疗老年人慢性脑部疾病相关的认知和行为障碍。
Cochrane Database Syst Rev. 2005 Apr 18(2):CD000269. doi: 10.1002/14651858.CD000269.pub3.

引用本文的文献

1
Spatial perspective taking is impaired in spinocerebellar ataxias and Friedreich ataxia.脊髓小脑共济失调和弗里德赖希共济失调患者的空间视角采择能力受损。
Sci Rep. 2025 Aug 24;15(1):31126. doi: 10.1038/s41598-025-16302-z.
2
Subjective memory complaints of patients and caregivers and their association with sociodemographic and clinical factors in patients with neurocognitive disorders from Colombia.哥伦比亚神经认知障碍患者及其照料者的主观记忆主诉及其与社会人口学和临床因素的关联
Res Sq. 2025 Jul 14:rs.3.rs-7040277. doi: 10.21203/rs.3.rs-7040277/v1.
3
Spatial navigation deficits in early Alzheimer's disease: the role of biomarkers and APOE genotype.
早期阿尔茨海默病中的空间导航缺陷:生物标志物和APOE基因型的作用。
J Neurol. 2025 Jun 2;272(6):438. doi: 10.1007/s00415-025-13151-8.
4
Self- and Informant-Report Cognitive Decline Discordance and Mild Cognitive Impairment Diagnosis.自我报告与知情者报告的认知衰退不一致性及轻度认知障碍诊断
JAMA Netw Open. 2025 Apr 1;8(4):e255810. doi: 10.1001/jamanetworkopen.2025.5810.
5
Neural markers of reduced arousal and consciousness in mild cognitive impairment.轻度认知障碍中觉醒和意识降低的神经标志物。
Int J Geriatr Psychiatry. 2024 Jun;39(6):e6112. doi: 10.1002/gps.6112.
6
Spatial navigation questionnaires as a supportive diagnostic tool in early Alzheimer's disease.空间导航问卷作为早期阿尔茨海默病的辅助诊断工具
iScience. 2024 Apr 26;27(6):109832. doi: 10.1016/j.isci.2024.109832. eCollection 2024 Jun 21.
7
Awareness and cognitive rehabilitation in Alzheimer's disease and frontotemporal dementia.阿尔茨海默病和额颞叶痴呆中的意识与认知康复
Alzheimers Dement (N Y). 2024 Apr 16;10(2):e12469. doi: 10.1002/trc2.12469. eCollection 2024 Apr-Jun.
8
The impact of informant-related characteristics including sex/gender on assessment of Alzheimer's disease symptoms and severity.包括性别在内的信息提供者相关特征对阿尔茨海默病症状及严重程度评估的影响。
Front Glob Womens Health. 2024 Mar 28;5:1326881. doi: 10.3389/fgwh.2024.1326881. eCollection 2024.
9
Multi-modal Neuroimaging Phenotyping of Mnemonic Anosognosia in the Aging Brain.衰老大脑中记忆性疾病失认症的多模态神经影像学表型分析
Commun Med (Lond). 2024 Apr 5;4(1):65. doi: 10.1038/s43856-024-00497-9.
10
Genetic Risk for Alzheimer's Disease Alters Perceived Executive Dysfunction in Cognitively Healthy Middle-Aged and Older Adults.阿尔茨海默病的遗传风险改变认知健康的中老年人对执行功能障碍的认知。
J Alzheimers Dis Rep. 2024 Feb 16;8(1):267-279. doi: 10.3233/ADR-230166. eCollection 2024.